(19)
(11)
EP 0 954 324 A1
(12)
(43)
Date of publication:
10.11.1999
Bulletin 1999/45
(21)
Application number:
97917819.0
(22)
Date of filing:
02.04.1997
(51)
International Patent Classification (IPC):
A61K
31/
00
( . )
A61K
39/
00
( . )
A61P
3/
00
( . )
A61P
37/
00
( . )
C07K
14/
47
( . )
C12N
15/
85
( . )
A61K
33/
06
( . )
A61K
39/
39
( . )
A61P
3/
10
( . )
A61P
37/
02
( . )
C07K
14/
74
( . )
A61K
38/
00
( . )
(86)
International application number:
PCT/US1997/005461
(87)
International publication number:
WO 1997/036601
(
09.10.1997
Gazette 1997/43)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
03.04.1996
US 19960014790P
(71)
Applicant:
ANERGEN, INC.
Redwood City, CA 94063 (US)
(72)
Inventors:
REICH, Eva-Pia
Los Altos, CA 94204 (US)
DESHPANDE, Shrikant
Fremont, CA 94555 (US)
(74)
Representative:
Brasnett, Adrian Hugh, et al
Mewburn Ellis York House 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)
(54)
CYCLIC PEPTIDE VACCINES FOR TREATMENT AND PREVENTION OF DIABETES